3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Neoplasm Metastasis
8
Breast Neoplasms
8
Recurrence
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Treatment for Metastatic or Locally Advanced Cervical Cancer
1
Thyroid Neoplasms
1
Thymoma
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
Paclitaxel
34
Carboplatin
27
pembrolizumab
20
Bevacizumab
16
Letrozole
13
Megestrol Acetate
10
Cisplatin
9
lenvatinib
8
olaparib
7
dostarlimab
7
Metformin
7
durvalumab
6
abemaciclib
6
Radiotherapy
6
Everolimus
6
niraparib
5
Specimen Handling
5
Nivolumab
5
Medroxyprogesterone Acetate
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
Fluorouracil
5
Docetaxel
5
Biopsy
5
temsirolimus
4
rucaparib
4
Oxaliplatin
4
Fulvestrant
4
Doxorubicin
4
sapanisertib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Endometrial Neoplasms
×
NVP-BKM120
×
Clear all
NCT01397877
2023-09-06
ENDOPIK
ARCAGY/ GINECO GROUP
Phase 2
Completed
24 enrolled
NCT01550380
2014-07-29
BKM120
University of Utah
Phase 2
Withdrawn